Cargando…

Changes in HCMV immune cell frequency and phenotype are associated with chronic lung allograft dysfunction

BACKGROUND: Human cytomegalovirus (HCMV) infection is common and often severe in lung transplant recipients (LTRs), and it is a risk factor associated with chronic lung allograft dysfunction (CLAD). The complex interplay between HCMV and allograft rejection is still unclear. Currently, no treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Rousselière, Amélie, Delbos, Laurence, Foureau, Aurore, Reynaud-Gaubert, Martine, Roux, Antoine, Demant, Xavier, Le Pavec, Jérôme, Kessler, Romain, Mornex, Jean-François, Messika, Jonathan, Falque, Loïc, Le Borgne, Aurélie, Boussaud, Véronique, Tissot, Adrien, Hombourger, Sophie, Bressollette-Bodin, Céline, Charreau, Béatrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175754/
https://www.ncbi.nlm.nih.gov/pubmed/37187736
http://dx.doi.org/10.3389/fimmu.2023.1143875
_version_ 1785040279674290176
author Rousselière, Amélie
Delbos, Laurence
Foureau, Aurore
Reynaud-Gaubert, Martine
Roux, Antoine
Demant, Xavier
Le Pavec, Jérôme
Kessler, Romain
Mornex, Jean-François
Messika, Jonathan
Falque, Loïc
Le Borgne, Aurélie
Boussaud, Véronique
Tissot, Adrien
Hombourger, Sophie
Bressollette-Bodin, Céline
Charreau, Béatrice
author_facet Rousselière, Amélie
Delbos, Laurence
Foureau, Aurore
Reynaud-Gaubert, Martine
Roux, Antoine
Demant, Xavier
Le Pavec, Jérôme
Kessler, Romain
Mornex, Jean-François
Messika, Jonathan
Falque, Loïc
Le Borgne, Aurélie
Boussaud, Véronique
Tissot, Adrien
Hombourger, Sophie
Bressollette-Bodin, Céline
Charreau, Béatrice
author_sort Rousselière, Amélie
collection PubMed
description BACKGROUND: Human cytomegalovirus (HCMV) infection is common and often severe in lung transplant recipients (LTRs), and it is a risk factor associated with chronic lung allograft dysfunction (CLAD). The complex interplay between HCMV and allograft rejection is still unclear. Currently, no treatment is available to reverse CLAD after diagnosis, and the identification of reliable biomarkers that can predict the early development of CLAD is needed. This study investigated the HCMV immunity in LTRs who will develop CLAD. METHODS: This study quantified and phenotyped conventional (HLA-A2pp65) and HLA-E-restricted (HLA-EUL40) anti-HCMV CD8(+) T (CD8 T) cell responses induced by infection in LTRs developing CLAD or maintaining a stable allograft. The homeostasis of immune subsets (B, CD4T, CD8 T, NK, and γδT cells) post-primary infection associated with CLAD was also investigated. RESULTS: At M18 post-transplantation, HLA-EUL40 CD8 T responses were less frequently found in HCMV(+) LTRs (21.7%) developing CLAD (CLAD) than in LTRs (55%) keeping a functional graft (STABLE). In contrast, HLA-A2pp65 CD8 T was equally detected in 45% of STABLE and 47.8% of CLAD LTRs. The frequency of HLA-EUL40 and HLA-A2pp65 CD8 T among blood CD8 T cells shows lower median values in CLAD LTRs. Immunophenotype reveals an altered expression profile for HLA-EUL40 CD8 T in CLAD patients with a decreased expression for CD56 and the acquisition of PD-1. In STABLE LTRs, HCMV primary infection causes a decrease in B cells and inflation of CD8 T, CD57(+)/NKG2C(+) NK, and δ2(−)γδT cells. In CLAD LTRs, the regulation of B, total CD8 T, and δ2(+)γδT cells is maintained, but total NK, CD57(+)/NKG2C(+) NK, and δ2(−)γδT subsets are markedly reduced, while CD57 is overexpressed across T lymphocytes. CONCLUSIONS: CLAD is associated with significant changes in anti-HCMV immune cell responses. Our findings propose that the presence of dysfunctional HCMV-specific HLA-E-restricted CD8 T cells together with post-infection changes in the immune cell distribution affecting NK and γδT cells defines an early immune signature for CLAD in HCMV(+) LTRs. Such a signature may be of interest for the monitoring of LTRs and may allow an early stratification of LTRs at risk of CLAD.
format Online
Article
Text
id pubmed-10175754
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101757542023-05-13 Changes in HCMV immune cell frequency and phenotype are associated with chronic lung allograft dysfunction Rousselière, Amélie Delbos, Laurence Foureau, Aurore Reynaud-Gaubert, Martine Roux, Antoine Demant, Xavier Le Pavec, Jérôme Kessler, Romain Mornex, Jean-François Messika, Jonathan Falque, Loïc Le Borgne, Aurélie Boussaud, Véronique Tissot, Adrien Hombourger, Sophie Bressollette-Bodin, Céline Charreau, Béatrice Front Immunol Immunology BACKGROUND: Human cytomegalovirus (HCMV) infection is common and often severe in lung transplant recipients (LTRs), and it is a risk factor associated with chronic lung allograft dysfunction (CLAD). The complex interplay between HCMV and allograft rejection is still unclear. Currently, no treatment is available to reverse CLAD after diagnosis, and the identification of reliable biomarkers that can predict the early development of CLAD is needed. This study investigated the HCMV immunity in LTRs who will develop CLAD. METHODS: This study quantified and phenotyped conventional (HLA-A2pp65) and HLA-E-restricted (HLA-EUL40) anti-HCMV CD8(+) T (CD8 T) cell responses induced by infection in LTRs developing CLAD or maintaining a stable allograft. The homeostasis of immune subsets (B, CD4T, CD8 T, NK, and γδT cells) post-primary infection associated with CLAD was also investigated. RESULTS: At M18 post-transplantation, HLA-EUL40 CD8 T responses were less frequently found in HCMV(+) LTRs (21.7%) developing CLAD (CLAD) than in LTRs (55%) keeping a functional graft (STABLE). In contrast, HLA-A2pp65 CD8 T was equally detected in 45% of STABLE and 47.8% of CLAD LTRs. The frequency of HLA-EUL40 and HLA-A2pp65 CD8 T among blood CD8 T cells shows lower median values in CLAD LTRs. Immunophenotype reveals an altered expression profile for HLA-EUL40 CD8 T in CLAD patients with a decreased expression for CD56 and the acquisition of PD-1. In STABLE LTRs, HCMV primary infection causes a decrease in B cells and inflation of CD8 T, CD57(+)/NKG2C(+) NK, and δ2(−)γδT cells. In CLAD LTRs, the regulation of B, total CD8 T, and δ2(+)γδT cells is maintained, but total NK, CD57(+)/NKG2C(+) NK, and δ2(−)γδT subsets are markedly reduced, while CD57 is overexpressed across T lymphocytes. CONCLUSIONS: CLAD is associated with significant changes in anti-HCMV immune cell responses. Our findings propose that the presence of dysfunctional HCMV-specific HLA-E-restricted CD8 T cells together with post-infection changes in the immune cell distribution affecting NK and γδT cells defines an early immune signature for CLAD in HCMV(+) LTRs. Such a signature may be of interest for the monitoring of LTRs and may allow an early stratification of LTRs at risk of CLAD. Frontiers Media S.A. 2023-04-28 /pmc/articles/PMC10175754/ /pubmed/37187736 http://dx.doi.org/10.3389/fimmu.2023.1143875 Text en Copyright © 2023 Rousselière, Delbos, Foureau, Reynaud-Gaubert, Roux, Demant, Le Pavec, Kessler, Mornex, Messika, Falque, Le Borgne, Boussaud, Tissot, Hombourger, Bressollette-Bodin and Charreau https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Rousselière, Amélie
Delbos, Laurence
Foureau, Aurore
Reynaud-Gaubert, Martine
Roux, Antoine
Demant, Xavier
Le Pavec, Jérôme
Kessler, Romain
Mornex, Jean-François
Messika, Jonathan
Falque, Loïc
Le Borgne, Aurélie
Boussaud, Véronique
Tissot, Adrien
Hombourger, Sophie
Bressollette-Bodin, Céline
Charreau, Béatrice
Changes in HCMV immune cell frequency and phenotype are associated with chronic lung allograft dysfunction
title Changes in HCMV immune cell frequency and phenotype are associated with chronic lung allograft dysfunction
title_full Changes in HCMV immune cell frequency and phenotype are associated with chronic lung allograft dysfunction
title_fullStr Changes in HCMV immune cell frequency and phenotype are associated with chronic lung allograft dysfunction
title_full_unstemmed Changes in HCMV immune cell frequency and phenotype are associated with chronic lung allograft dysfunction
title_short Changes in HCMV immune cell frequency and phenotype are associated with chronic lung allograft dysfunction
title_sort changes in hcmv immune cell frequency and phenotype are associated with chronic lung allograft dysfunction
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175754/
https://www.ncbi.nlm.nih.gov/pubmed/37187736
http://dx.doi.org/10.3389/fimmu.2023.1143875
work_keys_str_mv AT rousseliereamelie changesinhcmvimmunecellfrequencyandphenotypeareassociatedwithchroniclungallograftdysfunction
AT delboslaurence changesinhcmvimmunecellfrequencyandphenotypeareassociatedwithchroniclungallograftdysfunction
AT foureauaurore changesinhcmvimmunecellfrequencyandphenotypeareassociatedwithchroniclungallograftdysfunction
AT reynaudgaubertmartine changesinhcmvimmunecellfrequencyandphenotypeareassociatedwithchroniclungallograftdysfunction
AT rouxantoine changesinhcmvimmunecellfrequencyandphenotypeareassociatedwithchroniclungallograftdysfunction
AT demantxavier changesinhcmvimmunecellfrequencyandphenotypeareassociatedwithchroniclungallograftdysfunction
AT lepavecjerome changesinhcmvimmunecellfrequencyandphenotypeareassociatedwithchroniclungallograftdysfunction
AT kesslerromain changesinhcmvimmunecellfrequencyandphenotypeareassociatedwithchroniclungallograftdysfunction
AT mornexjeanfrancois changesinhcmvimmunecellfrequencyandphenotypeareassociatedwithchroniclungallograftdysfunction
AT messikajonathan changesinhcmvimmunecellfrequencyandphenotypeareassociatedwithchroniclungallograftdysfunction
AT falqueloic changesinhcmvimmunecellfrequencyandphenotypeareassociatedwithchroniclungallograftdysfunction
AT leborgneaurelie changesinhcmvimmunecellfrequencyandphenotypeareassociatedwithchroniclungallograftdysfunction
AT boussaudveronique changesinhcmvimmunecellfrequencyandphenotypeareassociatedwithchroniclungallograftdysfunction
AT tissotadrien changesinhcmvimmunecellfrequencyandphenotypeareassociatedwithchroniclungallograftdysfunction
AT hombourgersophie changesinhcmvimmunecellfrequencyandphenotypeareassociatedwithchroniclungallograftdysfunction
AT bressollettebodinceline changesinhcmvimmunecellfrequencyandphenotypeareassociatedwithchroniclungallograftdysfunction
AT charreaubeatrice changesinhcmvimmunecellfrequencyandphenotypeareassociatedwithchroniclungallograftdysfunction